SANDCAT
Jan 23 2023
A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of RO7200220 Administered Intravitreally in Patients with Uveitic Macular Edema (Sandcat)
Read MoreCapriCORN
Jan 23 2023
Comprehensive Analysis of Pathogens, Resistomes, and Inflammatory-markers in the Cornea
Read MoreRECORDATI MT8
Jan 23 2023
Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops (MT8) for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients
Read MoreIMVT TED
Jan 23 2023
A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
Read More
Clinical Trial Offers Hope to Patients with Dry Age-Related Macular Degeneration
Jan 10 2023
A current clinical trial could lead to approval of a first-ever treatment option for patients with geographic atrophy (GA) secondary to age-related macular degeneration, a progressive, irreversible, and devastating eye disease.
Read More
Funds Distribution Committee Supports New Projects
Sep 10 2021
The Funds Distribution Committee has announced a new round of projects selected to receive funding: Clinical Eye Research Unit’s purchase of an Optos Widefield Camera, $50,000 Ismail Zaitoun, PhD, and Nader Sheibani, PhD, for their…
Read More